Pending testing results, page-52

With regard to the lung cancer bard test, remember that the last lot of lung cancer data was NOT that good. The ovarian and breast data was far better and that’s the reason why they didn’t focus on lung cancer. That doesn’t mean they can’t tweak it to make it better but it explains the reason why lung cancer wasn’t prioritised. I would be surprised if it had anything to do with holding back results, in fact that would be illegal. We DO NOT know what the original agreement was with Dr Finger and the company. Maybe the company said they would focus on lung but didn’t. It will likely come down to whether or not the court considers BD1’s stance to not pursue lung cancer as being good commercial sense. My comment on not speculating is that we have NO IDEA what agreement was made between Dr Finger and BD1 so stop making up scenarios as they are pointless. Concentrate on what we do know and promote that.